Producer
WACKER Biosolutions (Cyclodextrins)
WACKER Chemie subsidiary producing pharmaceutical and food-grade cyclodextrins via enzymatic starch fermentation at Eddyville, Iowa. Uses Iowa corn starch as feedstock. CAVAMAX and CAVASOL brand cyclodextrins. One of the largest global pharmaceutical-grade HP-beta-CD producers. The Eddyville facility (former corn wet milling plant) is a unique example of agricultural biotechnology producing pharmaceutical excipients from midwestern corn.
0
Inputs supplied
0
Goods downstream
0
Facilities
0
Stories
What else they do
Business segments
The company's full revenue map — where this supply-chain role fits within their broader business.
CAVAMAX Cyclodextrins (Pharmaceutical)
50%CAVAMAX Food & Cosmetic Applications
25%Specialty Cyclodextrin Derivatives
15%Technical Services & Formulation Support
10%
Intelligence
What's known
Sourced claims about this company's role in supply chains — chokepoints, concentration, incidents, dual-use connections.
Origin2022
Wacker Chemie AG's CAVAMAX cyclodextrin product line, produced at Wacker's Burghausen, Bavaria facility, is one of the world's largest commercial cyclodextrin operations — and represents one of the most surprising product portfolio combinations in specialty chemicals. Wacker Chemie is simultaneously one of the three largest producers of polycrystalline silicon (for semiconductor wafers and solar cells), one of Europe's largest silicone manufacturers, and one of the world's leading cyclodextrin producers. These three businesses share little technically beyond the German chemical engineering tradition and the Burghausen manufacturing site's infrastructure. Wacker entered cyclodextrin production in the 1980s through a licensing relationship that gave it access to CGTase enzyme technology, and built industrial-scale cyclodextrin production that is now one of three or four global capacity centers. The CAVAMAX product line is used in pharmaceutical formulations (improving drug solubility), food applications (encapsulating flavors, reducing cholesterol in dairy products), and cosmetics — making a single Bavarian chemical facility simultaneously a dependency for drug manufacturers, dairy processors, and personal care companies. Wacker's polysilicon and cyclodextrin businesses are entirely unrelated in chemistry and supply chain, yet share a production campus — an industrial structure that reflects 20th century German chemical conglomerate logic rather than modern specialty chemical focused strategies.
Wacker Chemie AG ↗